Benralizumab, an Add-On Treatment for Severe Eosinophilic Asthma: Evaluation of Exacerbations, Emergency Department Visits, Lung Function, and Oral Corticosteroid Use
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s157171
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Informa UK Limited